Showing results (151-160 of 198) with videos related to
Sort By:
Pageof 20
Annals of Human Genetics|July 30, 2014
Global genetic architecture of an erythroid quantitative trait locus, HMIP-2Stephan Menzel, Helen Rooks, Diana Zelenika, et al.Blood. Red Cells & Iron|March 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell diseaseAnna Conrey, Nancy Asomaning, Ingrid Frey, et al.Plos One|August 13, 2013
Genome wide association analysis of a founder population identified TAF3 as a gene for MCHC in humansGiorgio Pistis, Shawntel U Okonkwo, Michela Traglia, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|December 10, 2016
Identifying the optimum source of mesenchymal stem cells for use in knee surgeryBenjamin M Davies, Sarah J B Snelling, Lynn Quek, et al.Hemasphere|April 16, 2026
Lower efficacy of transfusion of red blood cells from donors with sickle cell traitMonika Dzieciatkowska, Daniel Stephenson, Ariel Hay, et al.Blood Advances|February 14, 2018
g(HbF): a genetic model of fetal hemoglobin in sickle cell diseaseKate Gardner, Tony Fulford, Nicholas Silver, et al.BMC Hematology|November 22, 2018
A ten year review of the sickle cell program in Muhimbili National Hospital, TanzaniaJulie Makani, Furahini Tluway, Abel Makubi, et al.Haematologica|December 3, 2009
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemiasMaria Domenica Cappellini, John Porter, Amal El-Beshlawy, et al.Blood|May 16, 2022
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell diseaseJulia Z Xu, Anna Conrey, Ingrid Frey, et al.Blood Advances|January 5, 2024
In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantationAlexis K Leonard, Dana Furstenau, Zaina Inam, et al.Pageof 20